CMPX Compass Therapeutics Inc: Multiplikator nilai perusahaan marang pendapatan

Logo perusahaan publik compasstherapeutics.com (CMPX)

Patent protection for targeted antibodies minimizes price wars, which stimulates the implementation of automated molecule screening. The EV/Sales multiple valuation of Compass Therapeutics (CMPX) confirms this correlation, where the current status is 0.00. Strategic management of the scientific portfolio and clinical data ensures overall stability, transforming innovations into effective oncology treatment methods.

Nilai perusahaan marang pendapatan: Compass Therapeutics Inc (CMPX) kanggo 23.11.2025 - 19.11.2026

compasstherapeutics.com - rincian analitis lan metrik utama (CMPX)

- rega saham lan konsensus proyeksi valuasi:
Analisis wiwitan perusahaan:Compass Therapeutics CMPX
Sampel barang Compass Therapeutics

The absence of geopolitical barriers in the field of cancer immunotherapy provides Compass Therapeutics (CMPX) with a stable environment for global research. This business resilience is reflected in the EV/Sales ratio, which relates the total enterprise value to its revenue, excluding the impact of debt load. This metric allows for the valuation of each dollar of sales without distortions from the capital structure. Analyzing this figure reveals whether the asset is overbought or undervalued. The trajectory of the EV/Sales ratio serves as an indicator of the balance between fundamental value and market expectations.

Analisis pesaing Compass Therapeutics

IBRX (immunitybio.com) - Rasio nilai perusahaan marang pendapatan|Immunocore Corp (IMCR) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Janux Pharma (JANX)|Nilai perusahaan marang pendapatan RCUS|ZYME - Rasio nilai perusahaan marang dodolan|Nilai perusahaan marang pendapatan TNGX (Tango Pharma)|Koefisien nilai perusahaan marang pendapatan IOVA|Multiplikator EV/Sales IMTX (Immatics)|Nilai bisnis marang pendapatan XNCR|replimune.com - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Lyell Pharma|Innate Pharma S.A. (IPHA) - Rasio nilai perusahaan marang pendapatan|Pyxis Oncology Inc. - Nilai bisnis marang pendapatan|CGEN (Compugen Limited) - Multiplikator EV/Sales|Multiplikator EV/Sales IO Biotech Inc|Rasio nilai perusahaan marang pendapatan Sutro Biopharma (STRO)|INKT: Nilai perusahaan marang volume dodolan|Werewolf Therapeutics, Inc. - Nilai perusahaan marang pendapatan|Immix (IMMX) - Multiplikator nilai perusahaan marang pendapatan|ALX Oncology Holdings Inc. - Multiplikator EV/Sales|CUE - Multiplikator EV/Sales|PDSB: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Sonnet BioTherapeutics Holdings Inc. (SONN)|MAIA (MAIABiotech.com) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan Liminatus Pharma (LIMN)|Multiplikator EV/Sales LVTX|Koefisien nilai perusahaan marang pendapatan NXTC|Leap Therapeutics, Inc. - Nilai perusahaan marang pendapatan|INTS: Rasio nilai perusahaan marang pendapatan|Sensei Biotherapeutics Inc - Multiplikator EV/Sales|TOVX: Rasio nilai perusahaan marang pendapatan|gritstonebio.com (GRTS) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan KA|Rasio nilai perusahaan marang pendapatan NexImmune, Inc.|Rasio nilai perusahaan marang pendapatan TSBX (Turnstone Biologics)|Nilai perusahaan marang pendapatan VCNX (Vaccinex, Inc.)|Koefisien nilai perusahaan marang pendapatan HARP